ancitabine has been researched along with Experimental Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Floersheim, GL; Torhorst, J | 1 |
| Burchenal, JH; Chisholm, J; Kalaher, K; O'Toole, T | 1 |
| Stinner, G | 1 |
3 other study(ies) available for ancitabine and Experimental Leukemia
| Article | Year |
|---|---|
Inhibition by lymph node cells and promotion by fetal hepatocytes of murine tumours without or with chemotherapy.
Topics: Ancitabine; Animals; Antineoplastic Agents; Busulfan; Carcinogens; Cyclophosphamide; Female; Killer Cells, Natural; Leukemia, Experimental; Liver; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Moloney murine leukemia virus; Neoplasms, Experimental; Sarcoma, Experimental | 1981 |
Synergistic effects of the combination of cis-platinum diamminodichloride and 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in transplanted mouse leukemias.
Topics: Ancitabine; Animals; Cells, Cultured; Cisplatin; Cytarabine; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Leukemia L1210; Leukemia, Experimental; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Inbred DBA | 1977 |
The antitumor effect of syngeneic fetal liver cells and bone marrow cells in tumor-bearing mice.
Topics: Ancitabine; Animals; Bone Marrow Cells; Bone Marrow Transplantation; Hematopoiesis; Leukemia, Experimental; Liver; Liver Transplantation; Mice; Transplantation, Isogeneic | 1979 |